.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Research into PAICS breast cancer metastasis has revealed a crucial mechanism that drives tumor spread. Breast cancer remains a significant clinical challenge globally and in India. Therefore, identifying key regulatory factors like PAICS is essential for improving patient outcomes. Recent multi-omics analyses show that PAICS acts as a metabolic regulator. It specifically modulates the epithelial-mesenchymal transition (EMT) process, which is a hallmark of metastatic progression.
Metastasis involves a complex series of molecular changes where cancer cells lose their epithelial traits. Consequently, they acquire mesenchymal characteristics. These traits allow them to migrate and invade other tissues effectively. Study results demonstrate that PAICS knockdown significantly reduces the expression of mesenchymal markers like N-cadherin and Vimentin. Meanwhile, this process increases E-cadherin levels. Since E-cadherin is vital for cell-to-cell adhesion, its restoration suppresses the invasive potential of breast cancer cells.
Furthermore, PAICS expression correlates with the infiltration of various immune cell subsets. This correlation suggests that PAICS does not only affect tumor cells directly. It also alters the immune microenvironment to favor tumor survival. By integrating machine learning algorithms and miRNA expression profiles, researchers have constructed a robust regulatory network. This network highlights how PAICS serves as both a prognostic biomarker and a potential therapeutic target in clinical settings.
The identification of PAICS as a key regulator provides a new avenue for targeted therapy. Because it promotes metastasis by modulating both EMT and the immune microenvironment, inhibiting PAICS could potentially halt disease progression. Future clinical trials may focus on PAICS inhibitors to complement existing treatment regimens. Ultimately, these findings offer hope for more personalized and effective strategies in managing advanced breast cancer.
PAICS acts as a key regulator of the epithelial-mesenchymal transition (EMT). It promotes the migration and invasion of breast cancer cells by altering specific protein expressions.
Higher levels of PAICS expression are generally associated with poorer survival rates in patients. This is because the enzyme facilitates metastatic spread and modifies the immune response within the tumor.
Yes, because PAICS promotes tumor progression, researchers view it as a promising therapeutic target. Knocking down this gene has been shown to suppress the aggressive behavior of cancer cells in laboratory settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Guo J et al. Integrative multi-omics analysis identifies PAICS as a key regulator of epithelial-mesenchymal transition in breast cancer metastasis. Discov Oncol. 2026 Apr 14. doi: 10.1007/s12672-026-04968-4. PMID: 41979850.
Huo A, Xiong X. PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression. Life Sci. 2023 Oct 15;331:122070. doi: 10.1016/j.lfs.2023.122070.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New multi-omics research identifies PAICS as a key regulator of epithelial-mesenchymal transition (EMT) and immune microenvironment in breast cancer metasta...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
